Analyst Ratings for Cartesian Therapeutics (RNAC)
RNAC Rating Summary
RNAC Price Target Summary
- Highest: $50.00 (Oppenheimer)
- Lowest: $2.00 (H.C. Wainwright)
- Average: $32.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$32.75 (+76%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$32.75 (+76%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/4/2024 | Oppenheimer | N/A | New Coverage | Outperform (N/A) |
50.00 (N/A) |
36.00 (18.61) |
-48.31% | Details |
| 5/24/2024 | Mizuho | Uy Ear | New Coverage | Outperform (N/A) |
40.00 (N/A) |
25.46 (18.61) |
-26.9% | Details |
 |
||||||||
|
||||||||
